RBC Life Sciences Enters Taiwan Market
March 25, 2010 (FinancialWire) — RBC Life Sciences (OTCBB: RBC) — RBC Life Sciences, Inc., a provider of nutritional supplements, wound care and pain management products, said that it has begun selling nutritional supplements in Taiwan utilizing the Not for Resale model.
The NFR Program allows consumers in Taiwan to sign up as customers, purchase products, refer others to the program and receive commissions. The NFR Program also allows RBC Life Sciences' independent associates in the United States and Canada to build their domestic-based businesses in Taiwan.
RBC is initially offering only their flagship products in the country, through a dedicated Not For Resale Program. RBC said that additional products will be added later.
One of the five products currently offered through the NFR Program is NeuroBright, a patent-pending botanical and antioxidant product formulated to assist brain health.
Through U.S. and Canadian subsidiaries, RBC Life Sciences develops, manufactures and markets nutritional supplements and personal care products under its RBC Life brand. MPM Medical, the company's medical products subsidiary, develops and markets proprietary prescription and nonprescription products for advanced wound care and pain management.
FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.